About
Secretome Therapeutics develops scalable neonatal cell-based therapies derived from neonatal cardiac progenitor cells to treat heart failure and dilated cardiomyopathy, focusing on consistent, potent, and ethical stem cell therapies with ongoing early-stage clinical trials.
Explore Secretome Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.